213 related articles for article (PubMed ID: 27503069)
1. Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection.
Liu H; Jain R; Guan J; Vuong V; Ishido S; La Gruta NL; Gray DH; Villadangos JA; Mintern JD
J Exp Med; 2016 Aug; 213(9):1695-703. PubMed ID: 27503069
[TBL] [Abstract][Full Text] [Related]
2. Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83.
von Rohrscheidt J; Petrozziello E; Nedjic J; Federle C; Krzyzak L; Ploegh HL; Ishido S; Steinkasserer A; Klein L
J Exp Med; 2016 Aug; 213(9):1685-94. PubMed ID: 27503071
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitination of MHC Class II Is Required for Development of Regulatory but Not Conventional CD4
Liu H; Wilson KR; Schriek P; Macri C; Blum AB; Francis L; Heinlein M; Nataraja C; Harris J; Jones SA; Gray DHD; Villadangos JA; Mintern JD
J Immunol; 2020 Sep; 205(5):1207-1216. PubMed ID: 32747505
[TBL] [Abstract][Full Text] [Related]
4. LAMP2 regulates autophagy in the thymic epithelium and thymic stroma-dependent CD4 T cell development.
Rodrigues PM; Sousa LG; Perrod C; Maceiras AR; Ferreirinha P; Pombinho R; Romera-Cárdenas G; Gomez-Lazaro M; Senkara M; Pistolic J; Cabanes D; Klein L; Saftig P; Alves NL
Autophagy; 2023 Feb; 19(2):426-439. PubMed ID: 35535798
[TBL] [Abstract][Full Text] [Related]
5. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells.
Kuwano Y; Prazma CM; Yazawa N; Watanabe R; Ishiura N; Kumanogoh A; Okochi H; Tamaki K; Fujimoto M; Tedder TF
Int Immunol; 2007 Aug; 19(8):977-92. PubMed ID: 17804692
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.
Cho KJ; Walseng E; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10449-54. PubMed ID: 26240324
[TBL] [Abstract][Full Text] [Related]
7. GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-Antigen.
Rausch MP; Meador LR; Metzger TC; Li H; Qiu S; Anderson MS; Hastings KT
J Immunol; 2020 Jun; 204(11):2877-2886. PubMed ID: 32269095
[TBL] [Abstract][Full Text] [Related]
8. Thymocyte selection regulates the homeostasis of IL-7-expressing thymic cortical epithelial cells in vivo.
Ribeiro AR; Rodrigues PM; Meireles C; Di Santo JP; Alves NL
J Immunol; 2013 Aug; 191(3):1200-9. PubMed ID: 23794633
[TBL] [Abstract][Full Text] [Related]
9. MARCH ligases in immunity.
Liu H; Mintern JD; Villadangos JA
Curr Opin Immunol; 2019 Jun; 58():38-43. PubMed ID: 31063934
[TBL] [Abstract][Full Text] [Related]
10. The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells.
Su LL; Iwai H; Lin JT; Fathman CG
J Immunol; 2009 Jul; 183(1):438-44. PubMed ID: 19542455
[TBL] [Abstract][Full Text] [Related]
11. Low-Level MHC Class II Expression Leads to Suboptimal Th Cell Response, Increased Autoaggression, and Heightened Cytokine Inducibility.
Chen YT; Su YC; Chang ML; Tsai PF; Kung JT
J Immunol; 2017 Mar; 198(5):1928-1943. PubMed ID: 28108557
[TBL] [Abstract][Full Text] [Related]
12. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
13. Thymus-specific serine protease regulates positive selection of a subset of CD4+ thymocytes.
Gommeaux J; Grégoire C; Nguessan P; Richelme M; Malissen M; Guerder S; Malissen B; Carrier A
Eur J Immunol; 2009 Apr; 39(4):956-64. PubMed ID: 19283781
[TBL] [Abstract][Full Text] [Related]
14. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation.
Tze LE; Horikawa K; Domaschenz H; Howard DR; Roots CM; Rigby RJ; Way DA; Ohmura-Hoshino M; Ishido S; Andoniou CE; Degli-Esposti MA; Goodnow CC
J Exp Med; 2011 Jan; 208(1):149-65. PubMed ID: 21220452
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of CLIP:MHC class II and conventional endogenous peptide:MHC class II complexes by thymic epithelial cells and peripheral antigen-presenting cells.
Farr A; DeRoos PC; Eastman S; Rudensky AY
Eur J Immunol; 1996 Dec; 26(12):3185-93. PubMed ID: 8977321
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells.
Bensinger SJ; Bandeira A; Jordan MS; Caton AJ; Laufer TM
J Exp Med; 2001 Aug; 194(4):427-38. PubMed ID: 11514600
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitination of MHC Class II by March-I Regulates Dendritic Cell Fitness.
Kim HJ; Bandola-Simon J; Ishido S; Wong NW; Koparde VN; Cam M; Roche PA
J Immunol; 2021 Feb; 206(3):494-504. PubMed ID: 33318291
[TBL] [Abstract][Full Text] [Related]
18. Functional CD8+ but not CD4+ T cell responses develop independent of thymic epithelial MHC.
Martinic MM; van den Broek MF; Rülicke T; Huber C; Odermatt B; Reith W; Horvath E; Zellweger R; Fink K; Recher M; Eschli B; Hengartner H; Zinkernagel RM
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14435-40. PubMed ID: 16983067
[TBL] [Abstract][Full Text] [Related]
19. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells.
Young LJ; Wilson NS; Schnorrer P; Proietto A; ten Broeke T; Matsuki Y; Mount AM; Belz GT; O'Keeffe M; Ohmura-Hoshino M; Ishido S; Stoorvogel W; Heath WR; Shortman K; Villadangos JA
Nat Immunol; 2008 Nov; 9(11):1244-52. PubMed ID: 18849989
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells.
Ohmura-Hoshino M; Matsuki Y; Mito-Yoshida M; Goto E; Aoki-Kawasumi M; Nakayama M; Ohara O; Ishido S
J Immunol; 2009 Dec; 183(11):6893-7. PubMed ID: 19917682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
